MedPath

BOSTON MEDICAL CENTER

BOSTON MEDICAL CENTER logo
🇺🇸United States
Ownership
Private
Established
1996-01-01
Employees
1K
Market Cap
-
Website
http://www.bmc.org

Clinical Trials

316

Active:7
Completed:194

Trial Phases

6 Phases

Early Phase 1:5
Phase 1:21
Phase 2:30
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (275 trials with phase data)• Click on a phase to view related trials

Not Applicable
194 (70.5%)
Phase 2
30 (10.9%)
Phase 1
21 (7.6%)
Phase 4
13 (4.7%)
Phase 3
12 (4.4%)
Early Phase 1
5 (1.8%)

Cardiac Anodal Biphasic Pacing

Not Applicable
Not yet recruiting
Conditions
Cardiac Pacing
First Posted Date
2025-09-15
Last Posted Date
2025-09-15
Lead Sponsor
Boston Medical Center
Target Recruit Count
108
Registration Number
NCT07173777
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

MA-CEAL Community Health Ambassador Program

Not Applicable
Withdrawn
Conditions
Hypertension
Diabetes Mellitus
Health Care Utilization
First Posted Date
2025-08-22
Last Posted Date
2025-10-02
Lead Sponsor
Boston Medical Center
Target Recruit Count
750
Registration Number
NCT07136402
Locations
🇺🇸

12 housing developments from BHA and Trinity, Boston, Massachusetts, United States

Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care

Not Applicable
Not yet recruiting
Conditions
Delirium
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Boston Medical Center
Target Recruit Count
30
Registration Number
NCT07137949
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

Not Applicable
Not yet recruiting
Conditions
Congestive Heart Failure
Volume Overload
First Posted Date
2025-07-31
Last Posted Date
2025-07-31
Lead Sponsor
Boston Medical Center
Target Recruit Count
200
Registration Number
NCT07096726
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships

Not Applicable
Not yet recruiting
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2025-06-29
Last Posted Date
2025-10-08
Lead Sponsor
Boston Medical Center
Target Recruit Count
900
Registration Number
NCT07043426
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 64
  • Next

News

UCLA Launches First Large-Scale U.S. Trial Testing AI in Breast Cancer Screening

UCLA and UC Davis will co-lead the PRISM Trial, a $16 million randomized controlled study evaluating artificial intelligence support for mammogram interpretation across seven academic medical centers.

Insulin Access Disparities Persist Despite Cost Stabilization, Study Reveals Long-Term Health System Burden

A comprehensive analysis of insulin out-of-pocket costs and usage patterns from 2008-2021 reveals persistent disparities in insulin access between higher-income and lower-income patients with diabetes.

Modern Approaches to Joint Replacement Recovery: Faster Healing, Less Pain

Advancements in joint replacement techniques now allow patients to begin walking the same day as surgery, with most returning home within 24 hours of the procedure.

Global Surge in Early-Onset Colorectal Cancer Demands Urgent Attention

Colorectal cancer rates among young adults under 50 have increased in 27 out of 50 countries worldwide, with New Zealand, Chile, and Puerto Rico showing the highest annual growth rates of approximately 4%.

Novel EGFR Inhibitors and Early Detection: Dr. Geoff Oxnard Bridges Clinical Practice and Drug Development

Dr. Geoff Oxnard, CMO at Blossom Hill Therapeutics and thoracic oncologist at Boston Medical Center, is spearheading research on novel EGFR inhibitors to combat treatment resistance.

Diversity in Head and Neck Cancer Clinical Trials Declines, Study Finds

A recent study reveals that racial and ethnic diversity in head and neck cancer clinical trials in the U.S. has worsened over the past decade.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.